DNA甲基化与高脂血症的关系研究进展

doi:10.3969/j.issn.1673－5765.2023.04.003

摘要/Abstract

摘要： 高脂血症是心血管疾病的主要危险因素之一，且是可遗传、可干预的因素。较多研究发现，DNA甲基化修饰与血脂水平之间具有相关性，目前发现涉及的基因主要有肉碱棕榈酰转移酶1A（carnitine palmitoyl transferase 1 A，CPT1A）基因、三磷酸腺苷结合盒转运体G1（adenosine triphosphate binding cassette transporter G1，ABCG1）基因、固醇调控元件结合蛋白1（sterol regulatory element-binding factor 1，SREBF1）基因、肿瘤坏死因子诱导蛋白3相互作用蛋白1（tumor necrosis factor α-induced protein 3-interacting protein 1，TNIP1）基因、24-脱氢胆固醇还原酶（3-β-hydroxysteroid-Δ-24-reductase，DHCR24）基因等。另外，还有研究发现饮食与环境因素可以通过改变特定基因的甲基化水平影响血脂水平，可根据基因甲基化与血脂的关系寻找针对该基因靶点的降脂药物。然而，目前关于DNA甲基化与血脂水平关系的研究结论仍不一致，两者之间因果关系及潜在机制也尚未明确，未来还需要更多针对性的研究来探索DNA甲基化在高脂血症的诊断和治疗等临床实践中的应用价值。

文章导读： 综述现有针对DNA甲基化与血脂水平关系的研究结果，包括饮食环境因素和降脂药物对两者关系的影响，并展望未来研究方向。

关键词: 脱氧核糖核酸; 甲基化; 高脂血症; 表观遗传学; 脂质

Abstract: Hyperlipidemia is a major risk factor for cardiovascular disease, and blood lipid level can be hereditary and modifiable. Many studies have found correlation between DNA methylation and blood lipid levels, with specific genes involving this action process such as carnitine palmitoyl l transferase 1A (CPT1A) , adenosine triphosphate binding cassette transporter G1 (ABCG1) , sterol regulatory element-binding factor 1 (SREBF1) , tumor necrosis factor α-induced protein 3-interacting protein 1 (TNIP1) , and 3-β-hydroxysteroid-Δ-24-reductase (DHCR24). In addition, it has also been found that diet and environmental factors can influence blood lipid levels by altering the methylation levels of specific genes, and it is possible to identify lipid-lowering drugs targeting genes whose methylation level is correlated with blood lipid level. However, research findings on the relationship between DNA methylation and blood lipid level are inconsistent, and the causal relationship as well as the underlying mechanism between them remains unclear. Further research in the future is needed to explore the clinical value of DNA methylation in diagnosis and treatment of hyperlipidemia.

Key words: DNA; Methylation; Hyperlipidemia; Epigenetics; Lipid

韩颖, 周宏宇, 李子孝. DNA甲基化与高脂血症的关系研究进展[J]. 中国卒中杂志, 2023, 18(04): 388-395.

HAN Ying, ZHOU Hongyu, LI Zixiao. Progress of the Relationship between DNA Methylation and Hyperlipidemia[J]. Chinese Journal of Stroke, 2023, 18(04): 388-395.

参考文献

[1] TADA H，WON H H，MELANDER O，et al. Multiple associated variants increase the heritability explained for plasma lipids and coronary artery disease[J]. Circ Cardiovasc Genet，2014，7（5）：583-587.
[2] WILLER C J，SCHMIDT E M，SENGUPTA S，et al. Discovery and refinement of loci associated with lipid levels[J]. Nat Genet，2013，45（11）：1274-1283.
[3] GUAY S P，BRISSON D，LAMARCHE B，et al. ADRB3 gene promoter DNA methylation in blood and visceral adipose tissue is associated with metabolic disturbances in men[J]. Epigenomics，2014，6（1）：33-43.
[4] ALSALEH A，SANDERS T A，O’DELL S D. Effect of interaction between PPARG，PPARA and ADIPOQ gene variants and dietary fatty acids on plasma lipid profile and adiponectin concentration in a large intervention study[J]. Proc Nutr Soc，2012，71（1）：141-153.
[5] PATTERSON A D，SLANAR O，KRAUSZ K W，et al. Human urinary metabolomic profile of PPARalpha induced fatty acid beta-oxidation[J]. J Proteome Res，2009，8（9）：4293-300.
[6] LAI C Q，WOJCZYNSKI M K，PARNELL L D，et al. Epigenome-wide association study of triglyceride postprandial responses to a high-fat dietary challenge[J]. J Lipid Res，2016，57（12）：2200-2207.
[7] PFEIFFER L，WAHL S，PILLING L C，et al. DNA methylation of lipid-related genes affects blood lipid levels[J]. Circ Cardiovasc Genet，2015，8（2）：334-342.
[8] BRAUN K V E，DHANA K，DE VRIES P S，et al. Epigenome-wide association study（EWAS）on lipids：the Rotterdam study[J/OL]. Clin Epigenetics，2017，9：15[2022-12-10]. https://doi.org/10.1186/s13148-016-0304-4.
[9] REESKAMP L F，VENEMA A，PEREIRA J P B，et al. Differential DNA methylation in familial hypercholesterolemia[J/OL]. EBioMedicine，2020，61：103079[2022-11-12]. https://doi.org/10.1016/j.ebiom.2020.103079.
[10] DEKKERS K F，SLAGBOOM P E，JUKEMA J W，et al. The multifaceted interplay between lipids and epigenetics[J]. Curr Opin Lipidol，2016，27（3）：288-294.
[11] SMITH G D，EBRAHIM S. ‘Mendelian randomization’：can genetic epidemiology contribute to understanding environmental determinants of disease？[J]. Int J Epidemiol，2003，32（1）：1-22.
[12] DEKKERS K F，VAN ITERSON M，SLIEKER R C，et al. Blood lipids influence DNA methylation in circulating cells[J/OL]. Genome Biol，2016，17（1）：138[2022-11-12]. https://doi.org/10.1186/s13059-016-1000-6.
[13] ZAGHLOOL S B，MOOK-KANAMORI D O，KADER S，et al. Deep molecular phenotypes link complex disorders and physiological insult to CpG methylation[J]. Hum Mol Genet，2018，27（6）：1106-1121.
[14] SAYOLS-BAIXERAS S，TIWARI H K，ASLIBEKYAN S W. Disentangling associations between DNA methylation and blood lipids：a Mendelian randomization approach[J/OL]. BMC Proc，2018，12（Suppl 9）：23[2022-11-12]. https://doi.org/10.1186/s12919-018-0119-8.
[15] FRAMBACH S J C M，DE HAAS R，SMEITINK J A M，et al. Brothers in arms：ABCA1-and ABCG1-mediated cholesterol efflux as promising targets in cardiovascular disease treatment[J]. Pharmacol Rev，2020，72（1）：152-190 .
[16] NUOTIO M L，PERVJAKOVA N，JOENSUU A，et al. An epigenome-wide association study of metabolic syndrome and its components[J/OL]. Sci Rep，2020，10（1）：20567[2022-11-12]. https://doi.org/10.1038/s41598-020-77506-z.
[17] GOMEZ-ALONSO M D C，KRETSCHMER A，WILSON R，et al. DNA methylation and lipid metabolism：an EWAS of 226 metabolic measures[J/OL]. Clin Epigenetics，2021，13（1）：7[2022-11-12]. https://doi.org/10.1186/s13148-020-00957-8.
[18] GUAY S P，BRISSON D，LAMARCHE B，et al. Epipolymorphisms within lipoprotein genes contribute independently to plasma lipid levels in familial hypercholesterolemia[J]. Epigenetics，2014，9（5）：718-729.
[19] CAMPANELLA G，GUNTER M J，POLIDORO S，et al. Epigenome-wide association study of adiposity and future risk of obesity-related diseases[J]. Int J Obes（Lond），2018，42（12）：2022-2035.
[20] OLIVIER M，TANCK M W，OUT R，et al. Human ATP-binding cassette G1 controls macrophage lipoprotein lipase bioavailability and promotes foam cell formation[J]. Arterioscler Thromb Vasc Biol，2012，32（9）：2223-2231.
[21] GELISSEN I C，HARRIS M，RYE K A，et al. ABCA1 and ABCG1 synergize to mediate cholesterol export to ApoA-I[J]. Arterioscler Thromb Vasc Biol，2006，26（3）：534-540.
[22] AN F，LIU C，WANG X J，et al. Effect of ABCA1 promoter methylation on premature coronary artery disease and its relationship with inflammation[J/OL]. BMC Cardiovasc Disord，2021，21（1）：78[2022-11-12]. https://doi.org/10.1186/s12872-021-01894-x.
[23] FUJII R，YAMADA H，MUNETSUNA E，et al. Associations between dietary vitamin intake，ABCA1 gene promoter DNA methylation，and lipid profiles in a Japanese population[J]. Am J Clin Nutr，2019，110（5）：1213-1219 .
[24] GUAY S P，BRISSON D，MUNGER J，et al. ABCA1 gene promoter DNA methylation is associated with HDL particle profile and coronary artery disease in familial hypercholesterolemia[J]. Epigenetics，2012，7（5）：464-472.
[25] GUAY S P，LEGARE C，HOUDE A A，et al. Acetylsalicylic acid，aging and coronary artery disease are associated with ABCA1 DNA methylation in men[J/OL]. Clin Epigenetics，2014，29，6（1）：14[2022-11-12]. https://doi.org/10.1186/1868-7083-6-14.
[26] HOUDE A A，GUAY S P，DESGAGNE V，et al. Adaptations of placental and cord blood ABCA1 DNA methylation profile to maternal metabolic status[J]. Epigenetics，2013，8（12）：1289-1302.
[27] HORTON J D，GOLDSTEIN J L，BROWN M S. SREBPs：activators of the complete program of cholesterol and fatty acid synthesis in the liver[J]. J Clin Invest，2002，109（9）：1125-1131.
[28] YOKOYAMA C，WANG X，BRIGGS M R，et al. SREBP-1，a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene[J]. Cell，1993，75（1）：187-197.
[29] SMOLLE E，HAYBAECK J. Non-coding RNAs and lipid metabolism[J]. Int J Mol Sci，2014，15（8）：13494-13513.
[30] NAJAFI-SHOUSHTARI S H，KRISTO F，LI Y X，et al. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis[J]. Science，2010，328（5985）：1566-1569.
[31] FLORES A M，GUREVICH I，ZHANG C，et al. TNIP1 is a corepressor of agonist-bound PPARs[J]. Arch Biochem Biophys，2011，516（1）：58-66.
[32] GUREVICH I，ANESKIEVICH B J. Liganded RAR alpha and RAR gamma interact with but are repressed by TNIP1[J]. Biochem Biophys Res Commun，2009，389（3）：409-414.
[33] CHINETTI G，LESTAVEL S，BOCHER V，et al. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway[J]. Nat Med，2001，7（1）：53-58.
[34] LI A C，BINDER C J，GUTIERREZ A，et al. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARα，β/δ，and γ [J]. J Clin Invest，2004，114（11）：1564-1576.
[35] AYAORI M，YAKUSHIJI E，OGURA M，et al. Retinoic acid receptor agonists regulate expression of ATP-binding cassette transporter G1 in macrophages[J]. Biophys Acta，2012，1821（4）：561-572.
[36] DRZEWINSKA J，WALCZAK-DRZEWIECKA A，RATAJEWSKI M. Identification and analysis of the promoter region of the human DHCR24 gene：involvement of DNA methylation and histone acetylation[J]. Mol Biol Rep，2011，38（2）：1091-1101.
[37] ZERENTURK E J，SHARPE L J，IKONEN E，et al. Desmosterol and DHCR24：unexpected new directions for a terminal step in cholesterol synthesis[J]. Prog Lipid Res，2013，52（4）：666-680.
[38] DAIMIEL L A，FERNANDEZ-SUAREZ M E，RODRIGUEZ-ACEBES S，et al. Promoter analysis of the DHCR24（3beta-hydroxysterol Delta（24）-reductase）gene：characterization of SREBP（sterol-regulatory-element-binding protein）-mediated activation[J]. Biosci Rep，2012，33（1）：57-69.
[39] WU L J，ZHAO X Y，SHEN Y，et al. Promoter methylation of fas apoptotic inhibitory molecule 2 gene is associated with obesity and dyslipidaemia in Chinese children[J]. Diab Vasc Dis Res，2015，12（3）：217-220.
[40] HOUDE A A，LÉGARÉ C，BIRON S，et al. Leptin and adiponectin DNA methylation levels in adipose tissues and blood cells are associated with BMI，waist girth and LDL-cholesterol levels in severely obese men and women[J/OL]. BMC Med Genet，2015，16：29[2022-11-12]. https://doi.org/10.1186/s12881-015-0174-1.
[41] TOBI E W，SLIEKER R C，LUIJK R，et al. DNA methylation as a mediator of the association between prenatal adversity and risk factors for metabolic disease in adulthood[J/OL]. Sci Adv，2018，4（1）：eaao4364[2022-11-12]. https://doi.org/10.1126/sciadv.aao4364.
[42] SHEN L Q，LI C W，WANG Z H，et al. Early-life exposure to severe famine is associated with higher methylation level in the IGF2 gene and higher total cholesterol in late adulthood：the genomic research of the Chinese famine（GRECF）study[J/OL]. Clin Epigenetics，2019，11（1）：88[2022-11-12]. https://doi.org/10.1186/s13148-019-0676-3.
[43] ALI O，CERJAK D，KENT J W，et al. Methylation of SOCS3 is inversely associated with metabolic syndrome in an epigenome-wide association study of obesity[J]. Epigenetics，2016，11（9）：699-707.
[44] LAI C Q，PARNELL L D，SMITH C E，et al. Carbohydrate and fat intake associated with risk of metabolic diseases through epigenetics of CPT1A[J]. Am J Clin Nutr，2020，112（5）：1200-1211.
[45] OHASHI K，MUNETSUNA E，YAMADA H，et al. High fructose consumption induces DNA methylation at PPARalpha and CPT1A promoter regions in the rat liver[J]. Biochem Biophys Res Commun，2015，468（1/2）：185-189.
[46] LU X L，FRASZCZYK E，MEER T P，et al. An epigenome-wide association study identifies multiple DNA methylation markers of exposure to endocrine disruptors[J/OL]. Environ Int，2020，144：106016[2022-11-12]. https://doi.org/10.1016/j.envint.2020.106016.
[47] SONG Y，ZHOU T，ZONG Y Q，et al. Arsenic inhibited cholesterol efflux of THP-1 macrophages via ROS-mediated ABCA1 hypermethylation[J/OL]. Toxicology，2019，424：152225[2022-11-12]. https://doi.org/10.1016/j.tox.2019.05.012.
[48] YANG Z W，ZHAO J，WANG J，et al. Effects of cyclocarya paliurus polysaccharide on lipid metabolism-related genes DNA methylation in rats[J/OL]. Int J Biol Macromol，2019，123：343-349[2022-11-12]. https://doi.org/10.1016/j.ijbiomac.2018.11.110.
[49] YUSUF N，HIDALGO B，IRVIN M R，et al. An epigenome-wide association study of inflammatory response to fenofibrate in the genetics of lipid lowering drugs and diet network[J]. Pharmacogenomics，2017，18（14）：1333-1341.
[50] MOHAMMADZADEH N，MONTECUCCO F，CARBONE F，et al. Statins：epidrugs with effects on endothelial health？[J/OL]. Eur J Clin Invest，2020，50（12）：e13388[2022-11-12]. https://doi.org/10.1111/eci.13388.
[51] OCHOA-ROSALES C，PORTILLA-FERNANDEZ E，NANO J，et al. Epigenetic link between statin therapy and type 2 diabetes[J]. Diabetes Care，2020，43（4）：875-884.